With about 85% of the proteome currently undrugged, accessing these targets that are, at present, extremely difficult to drug, has prevented researchers from achieving desired clinical successes. The 2nd Proteome- […]

Solving the Translational Drug Development Gap, From Fibrotic Mechanisms to Clinically Effective Therapeutics. Now in its 4th year, the digital AFDD summit is the industry’s definitive guide to turning mechanistic […]

The 3rd Lifecycle Management for Combination Products Summit is the only dedicated meeting focusing on Lifecycle Management (LCM) and perfecting design control. This year the meeting will unite senior combination […]

As the industry grapples with unprecedented challenges, join us for our first ever Clinical Operations in Oncology Trials USA Virtual Experience brought to you directly in the comfort of your […]

Discover the Next Generation of CRISPR Tools to Enhance Specificity, Reduce Off-Target Effects & Transform Gene Editing into a Clinical Reality CRISPR is one of the most powerful discoveries of […]